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Activation of Intracellular Calcium byMultiple Wnt Ligands
and Translocation of -Catenin into the Nucleus
A CONVERGENTMODELOFWnt/Ca2 ANDWnt/-CATENIN PATHWAYS*□S
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Building, University Street, University College London, LondonWC1E 6JJ, United Kingdom, the §MRC Centre for Reproductive
Health, QueensMedical Research Institute, University of Edinburgh, 47 Little France Crescent, Edinburgh EH16 4TJ, United
Kingdom, and the ¶Prostate Cancer Research Centre, Division of Surgery, 3rd Floor Laboratories, Charles Bell House, 67 Riding
House Street, University College London, London W1W 7EJ, United Kingdom
Background: Cellular transducers of Wnt signaling, -catenin and Ca2, are considered to act via independent canonical
and non-canonical pathways.
Results: Six Wnt ligands activated cytosolic and intranuclear Ca2 and nuclear translocation of -catenin.
Conclusion:Wnt -catenin and Ca2 signaling are coupled in mammalian cells.
Significance: A coupled model of Wnt/Ca2 and -catenin signaling that challenges the canonical and non-canonical catego-
rization is proposed.
Ca2 and -catenin, a 92-kDa negatively charged transcrip-
tion factor, transduce Wnt signaling via the non-canonical,
Wnt/Ca2 and canonical, Wnt/-catenin pathways indepen-
dently. The nuclear envelope is a barrier to large protein entry,
and this process is regulatedby intracellular calcium [Ca2]i and
trans-nuclear potential. How -catenin traverses the nuclear
envelope is not well known. We hypothesized that Wnt/Ca2
and Wnt/-catenin pathways act in a coordinated manner and
that [Ca2]i release facilitates -catenin entry into the nucleus
in mammalian cells. In a live assay using calcium dyes in PC3
prostate cancer cells, six Wnt peptides (3A, 4, 5A, 7A, 9B, and
10B) mobilized [Ca2]i but Wnt11 did not. Based upon dwell
time (range  15–30 s) of the calcium waveform, these Wnts
could be classified into three classes: short, 3A and 5A; long, 7A
and 10B; and very long, 4 and 9B.Wnt-activated [Ca2]i release
was followed by an increase in intranuclear calcium and the
depolarization of both the cell and nuclear membranes, deter-
mined by using FM4-64. In cells treated with Wnts 5A, 9B, and
10B, paradigm substrates for each Wnt class, increased [Ca2]i
was followedby-catenin translocation into thenucleus inPC3,
MCF7, and 253J, prostate, breast, and bladder cancer cell lines;
both the increase in Wnt 5A, 9B, and 10B induced [Ca2]i
release and -catenin translocation are suppressed by thapsi-
gargin in PC3 cell line. We propose a convergent model of Wnt
signaling network where Ca2 and -catenin pathways may act
in a coordinated, interdependent, rather than independent,
manner.
Wnt (1) binding to its plasma membrane receptors (Frizzled
or FZDs (2)) can activate multiple intracellular transducers
(3–6), including the twomajor transducers-catenin andCa2
via the canonical or non-canonical signaling pathways, respec-
tively (7). Activation of gene transcription via canonical, Wnt/
-catenin signaling is the most studiedWnt pathway (7) and is
known to play a key role in development and disease (8).
Canonical signaling pathway leads to desequesterization of
-catenin from a multiprotein complex (9) followed by activa-
tion of transcription of LEF/TCF responsive genes. However,
events downstream of receptor activation are dependent upon
translocation of desequestered cytosolic-catenin, a negatively
charged 92-kDa protein, traversing the nuclear envelope (NE)2
to enter the nucleoplasm (10). Activation of the non-canonical,
-catenin-independent, Wnt/Ca2pathway results in the
mobilization of free intracellular calcium [Ca2]i (11) that reg-
ulates many cellular processes (12, 13), including cytoskeleton
and cell motility of prostate cancer cells (14). The so-called
canonical and the non-canonical pathways are considered to
operate independently (15) or antagonistically (16–18). Such
binary distinctions of Wnt signaling have come under scrutiny
recently (19) (20), but this interpretation has been challenged
rarely and only for one ligand of the 19 Wnt ligands, namely,
Wnt5A (21, 22).
The NE acts as a barrier that limits ion and macromolecular
exchange into the nucleoplasm. NE consists of an inner nuclear
membrane facing the nuclear lamina, separated by a cisterna
from the outermembrane that is contiguouswith the endoplas-
mic reticulum. Invaginations of the supramolecular nuclear
pore complex (NPC) provide the only route for the exchange of
matter (with an upper limit of90–100 kDa) between the cell
cytoplasm and nucleoplasm (23). Macromolecular transport
across the NE is a complex process requiring protein recogni-
* This work was supported by the Prostate Cancer Research Centre Charity
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tion by specific amino acid motifs (e.g. nuclear localization sig-
nal sequence or theArmadillo domain repeat sequences) on the
imported protein, first binding to the outer membrane of the
NE and then traversing through the NPC by an energy expend-
iture mechanism such as GTPase Ran/transport receptor path-
ways (24). The 92-kDa -catenin, unlike small macromolecules
(10 kDa, (25)) is at the upper limit for macromolecule entry
through the NPC into the nucleoplasm and does not involve
simple diffusion (9) or the Ran GTPase pathway (26–28), sug-
gesting that -catenin may encounter a considerable hurdle to
traverse the NE.
The NE is also an ion-selective membrane with a dynamic
trans-NE electrical potential that is responsive to changes in
Ca2 and K concentrations (reviewed byMazzanti et al. (23)).
Cytosolic [Ca2]i regulates nuclearCa2 concentration (29); an
increase in nucleoplasmic Ca2 facilitates transport of large
macromolecules (10 kDa) across the NE (25, 30, 31), whereas
a decrease in nucloeplasmic Ca2 inhibits trans-NEmacromo-
lecular transport (25, 32–34). The cell nucleus has been termed
a “negatively charged sink” (23) consisting largely of negatively
charged DNA and regions of nucleosome core proteins (35). In
HeLa cells, the trans-NE potential has been measured at 43
mVwith an estimated electrical pore diameter of 11 m2 (23,
36). In addition to its bulk, the -catenin protein has an overall
negative charge (20.8 at pH 7.0). Thus, the NE presents a
physical as well as an electrical barrier for -catenin entry into
the nucleoplasm, indicating a physicoelectrochemical mecha-
nism for -catenin translocation across the NE.
We hypothesized that a Wnt-mediated increase in [Ca2]i
leads to an increase in the nucleoplasmic calcium and depolar-
ization of NE that facilitates the passage of -catenin across the
NE. Identity of Wnts that can activate [Ca2]i release in mam-
malian cells is not well characterized. In prostate cancer cells,
Wnt5A induces a large increase in [Ca2]i (14), but it is not
known whether this causes an increased nucleoplasmic Ca2
and depolarization of the NE, and if there is subsequent trans-
location of -catenin to the nucleoplasm. To test our hypothe-
sis, we first determined (i) whether Wnts other than Wnt5A
also increase in [Ca2]i; (ii) that increase in [Ca2]i due toWnt/
Ca2 signaling activation results in depolarization of nuclear
membranes; (iii) that in cells, activated bymultipleWnt ligands,
-catenin is translocated into the nucleus. By using a live fluo-
rochrome assay and subsequent assessment of -catenin trans-
location to nucleoplasm in Wnt ligand-activated mammalian
cancer cell lines (PC3, prostate, MCF7, breast, and 253J blad-
der cell lines), we demonstrate that a number of Wnt ligands
increase intracellular and intranuclear Ca2, with distinct
kinetics, depolarization of the NE and translocation of
-catenin to the nucleus; both the increase in Wnt induced
[Ca2]i release and -catenin translocation are suppressed by
thapsigargin, an inhibitor of microsomal Ca2-ATPase (37). A
model in which Wnt/Ca2 and Wnt/-catenin pathways are
coupled rather than independent, as thought previously, is
proposed.
EXPERIMENTAL PROCEDURES
Cell Lines—All cell lines (PC3, prostate cancer,MCF7, breast
cancer, 253J bladder cancer, and Cos 7 simian kidney) were
obtained from ATCC via John R. W. Masters, University Col-
lege London and cultured in RPMI 1640 (Invitrogen) medium
containing 5 mM L-glutamine and FBS.
Wnt Peptides—Recombinant Wnt (3A, 4, 5A, 7A, 9B, 10B,
and 11) peptides were purchased from R&D Systems (Minne-
apolis, MN). Wnt-peptide stock solutions were prepared in
PBS.
[Ca2]i and Membrane Potential Imaging—The imaging
protocol was developed in our laboratory and has been
described in detail elsewhere (14). Briefly, 100000-200000 PC3,
MCF7, 253J, or Cos 7 cells were plated on 35-mm FluoroDish
(World Precision Instruments) and grown for 48 h; calcium
indicators Fluo-4 (Invitrogen) and FuraRed (Invitrogen) at 1
ng/mlwere added to FluoroDish containing only 1ml of culture
medium and incubated for 15–20 min at 37 °C. The culture
mediumwas removed and washed (2) and replaced with 1ml
of PBS (GIBCO). Live cell calcium imaging was performed on
anOlympus FluoView FV 1000 confocal microscope (Olympus
KeyMed) equipped with a 20 dry objective (numerical aper-
ture  0.75). Calcium indicators were excited with an argon
laser line (488 nm), and emissions were recorded in the green
channel (500–560 nm) for Fluo-4 and red channel (600–700
nm) for FuraRed after addition of vehicle control (PBS) orWnt
X (30–600 ng/ml). Images were acquired every 1.1 or 2.2 s for
up to 600–800s; image and data acquisition was performed
using FluoView 1000 software (Olympus). Fluorescent inten-
sity was measured and data exported as a tab delimited file for
further analysis using a spreadsheet. All imaging experiments
were performed in duplicate; intracellular calcium was meas-
ured in at least 3–12 different passages (passage numbers 25 to
37) of cell line for each Wnt ligand at 100 ng/ml. Wnt 11 was
tested in at least five different passages at three different con-
centrations. To test whether theWnt-activated calcium release
was from [Ca2]i stores, in some cases PC3 cells, loaded with
calcium dyes, were incubated with 1–5 M of thapsigargin
(Sigma), resuspended in dimethyl sulfoxide, for 20min at 37 °C,
prior to addition of Wnt ligand and live calcium imaging (as
described above).
Experimentswith themembrane potential sensitive dye FM4
64 (Invitrogen) and Fluo4 were performed in exactly the same
manner as for the Fluo4/FuraRed but with different emission
spectra detection for the FM4 64 indicator, i.e. excitation with
488 nm for both indicators and emission detection at 500–560
nm for Fluo4 and 650–800 for FM4-64. All other imaging/data
acquisition conditions were the same as above.
The experiments were performed using a 35-mm, glass-bot-
tomed FluoroDish containing 1 ml of PBS at 37 °C to which
ligands were added at desired concentration. In a static, non-
superfusing assay system, there is a lag time before the start of a
response, in this case, an increase in the intensity of the Fluo4
signal due to the release of free calcium. To measure the diffu-
sion constant under these conditions, we used pontamine sky
blue (Sigma), which fluoresces in the red spectrumwith an exci-
tation of 488 nm, using the standard practice for adding ligands;
the diffusion constant was measured to be 23.3  2.1 ms1
(means  S.E., n  8). The calcium wave (supplemental Mov-
ies), in response toWnt ligands, traveled across the FluoroDish.
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Data Analysis—After image acquisition, regions of interest
were drawn over individual PC3 cells (up to 25) in a single
frame, and calcium intensity measurements were made using
FluoView 1000 software (Olympus). The measurements were
exported as a tab-delimited file into a spreadsheet for further
analysis, and Fluo4/Fura Red ratios were calculated. The wave-
form, a product of the ratio of Fluo4 and FuraRed over the
period of measurement was used to measure the kinetics of the
activation of [Ca2]i release in PC3 cells in response to different
Wnt ligands. The time constants (rise, dwell, and fall times)
were calculated by first fitting the Fluo4/FuraRed ratio to a
single Gaussian function (OriginLab Corp.); a lower (10%) and
upper (90%) amplitude thresholding method was then used to
calculate the time constants (s). Statistical significance was cal-
culated using Mann-Whitney U test.
Immunocytochemistry of Mammalian Cell Lines—Immuno-
staining was performed in two different laboratories, indepen-
dently, with the experimenter blind to the identity of the treat-
ment. Either cells used in FluoroDish, post [Ca2]i experiments
using dyes (see above), or grown in eight-well chamber glass
slides (Lab Tek II, Nunc) were used. ForWnt ligand treatment,
the culture medium replaced with PBS (without calcium) at
37 °C. The experiments were replicated forWnt ligand or vehi-
cle control as described for [Ca2]imeasurements. Briefly,Wnt
ligands were added and chamber slides incubated at 37 °C for
up to 20 min. Chamber wells were washed 3 with 0.5 ml of
PBS, and cells were fixed with 0.5 ml of 4% formalin for 30 min
at 4 °C. Cells were washed 3 with ice-cold PBS and stored in
0.5ml of PBS at 4 °C for immunostaining. In some experiments,
PC3 cells were treated with thapsigargin as described above.
For immunostaining, cells were washed twice for 5 min in
TBST (20 mM Tris, pH 7.4, 0.9% NaCl, 0.1% Tween 20; Sigma).
Cells were then incubated in 20% normal goat serum/TBST for
30 min at room temperature, the chambers were drained, and
cells were incubated with mouse anti--catenin (ab22656,
Abcam) at 1:500 dilution in normal goat serum/TBST over-
night at 4 °C. Following two further 5-min washes in TBST,
sections were incubated in goat anti-mouse peroxidase Fab
(Abcam) at 1:500 dilution for 30 min at room temperature.
Following a further two 5-minwashes in TBST, cells were incu-
bated with tyramide Cy3 (PerkinElmer Life Science) for 10 min
at room temperature. Sections were washed twice for 5 min in
TBST before nuclear counterstaining with DAPI. After a final
two 5-minwashes, the chambers were removed, and a coverslip
was placed on slides using Permafluor (Thermo Shandon).
Imaging and Quantitation for -Catenin Expression and
Nuclear Co-localization Analysis—Fluorescence immunocyto-
chemical staining for -catenin expression in cell lines was
imaged using Olympus Fluoview 1000 confocal system (Olym-
pus KeyMed) mounted on an Olympus IX81 inverted micro-
scope using a 20 0.7 numerical aperture or 40 1.0 numer-
ical aperture dry objective with a zoom of 3. DAPI (nuclear
counterstain) was excited at 405 nm with an emission of 415–
500 nm; Cy3 (-catenin-labeled) signal was excited at 561 nm
with an emission spectrumbetween 570–670 nm. Laser power,
gain, and off-set settings for the photomultipler tubeswere kept
similar for comparable samples. Z-stacks of at least three fields
per samplewere imaged and saved inOlympus FV (OIF orOIB)
file format.
Nuclear co-localization of -catenin was calculated by
importing FV files for untreated, control, or treated cells, into
colocalization plug-in of Fiji software (38) for Cy3 (-catenin)
and DAPI (nuclear) signals. Pearson co-relation of colocaliza-
tion were tabulated for 25–90 cells (from two to five different
passages of cells) using regions of interest analysis. Statistical
significance between untreated and treated cells was calculated
using a Mann-Whitney U test.
Western Blotting—Cell membrane fraction from control
untreated andWnt-treated PC3 andMCF7cells was isolated by
differential centrifugation. Protein was quantified using a BCA
protein assay and 10g/lanewas loaded onto a 10% SDS-PAGE
gel. Samples were treatedwith protease and phosphatase inhib-
itors (Roche Applied Science). The resolved protein was trans-
ferred onto a PVDF membrane and that was cut into strips of
250 to 75 and 70–35 kDa as visualized by using Rainbowmolec-
ular weight markers (Invitrogen). The two PVDF membrane
strips were probed with the following antibodies: anti-phos-
pho-LRP-6 (Ser-1490) that detects human LRP-6 when phos-
phorylated at Ser-1490 in Western blots (200 kDa, R&D Sys-
tems, AF6649, 2.5g/ml) and -actin (42 kDa, Abcam, ab6276,
1:5000 (diluted)). Following incubation with appropriate sec-
ondary antibodies and ECL detection, the blots were exposed
on Kodak BioMax light film (Carestream Health) in an autora-
diography cassette.
Scratch Wound Assay—PC3 cells were grown in 24-well
ImageLock plates (Essen Bioscience) to confluency and scratched
using a wound maker device (Essen Bioscience). Imaging (at 2h
intervals) and quantitation of wound width was performed as
described previously (14) using Incucyte (Essen Bioscience).
The rate of wound closure (Wnts and thapsigargin) was cal-
culated by fitting the line using linear regression function in
Origin software (OriginLab, Corp.). Statistical significance of
difference between the slopes for untreated and treated sam-
ples was calculated using F-test.
RESULTS
We have shown previously that Wnt/Ca2 signaling is a key
regulator of cytoskeleton and motility in PC3 cells with a 2.5-
fold increase in [Ca2]i (14). Little is known about the ability of
Wnts to induce [Ca2]i release in mammalian cells, except that
Wnt5A induces intracellular Ca2 release in prostate cells. The
first question we sought to answer was which other Wnts
induce [Ca2]i release in PC3 cell lines?
[Ca2]i Release in Response to Wnt Ligands—Addition of all
Wnt ligands tested, with the exception of Wnt11, caused a
change in ratio of Fluo4/Fura Red in PC 3 cells (supplemental
Movies SM1–SM8). The ratio of Fluo4/FuraRed was plotted as
a function of time (Fig. 1, representative trace for all Wnts
tested), and the waveform was used to measure the kinetics of
the activation of [Ca2]i in PC3 cells in response to different
Wnt ligands. Parameters such as the amplitude and time con-
stants (rise, dwell, and fall times) were calculated by first fitting
the Fluo4/FuraRed ratio to a single Gaussian function.We then
used a lower (10%) and upper (90%) amplitude thresholding
method to calculate the timing parameters. The amplitude for
ANew, ConvergentModel ofWnt Signaling inMammalian Cells
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[Ca2]i release in response to Wnt ligands represents the peak
of the calciumwaveform. The amplitude of calcium release was
Wnt ligand concentration-dependent (supplemental Fig. S1). A
number of Wnt ligands (e.g. 5A, 9B, and 10B) also activated
[Ca2]i release in MCF7 and 253J human breast and urinary
tract cell lines, respectively (supplemental Movies SM9 –
SM12), indicating that this phenomenon was not specific to
PC3 cell line. Furthermore, Wnt5A also activated [Ca2]i in
Cos7 simian kidney cell line (supplemental Movie SM13).
Thapsigargin is an inhibitor of the endoplasmic reticulum
Ca2-ATPase and depletes [Ca2]i stores (37). Thapsigargin
has been used previously to investigate ligand-induced [Ca2]i
release (39). The increase in [Ca2]i in response toWnt ligands
tested (5A, 9B, and 10B) was abolished after treatment of PC3
cells with thapsigargin (5 M) (Fig. 2). These results indicate
that depletion of [Ca2]i abolishes Wnt induced [Ca2]i
release.
Rise, Dwell, and Fall Time of [Ca2]i Release—Time con-
stants for the rise, dwell, and fall time of [Ca2]i release in
response to Wnt peptides (100 ng/ml) were calculated as
described under “Experimental Procedures” and shown in Fig.
3. Wnt3A and Wnt5A showed the shortest rise and fall time,
whereasWnt 9B andWnt4 showed the slowest rise and fall time
(Fig. 3, A and C). DTs reflect the time the [Ca2]i signal was
sustained at peak amplitude after application of Wnt peptides.
The DT analysis (Fig. 3B) indicates that of the sixWnts activat-
ing [Ca2]i release could be classified into three classes: short,
3A and 5A (DT 15 s); long, 7A and 10B (DT 25 s); and very
long, 4 and 9B (DT 30 s).
Wnt Ligands Activate Calcium by a Negative Cooperative
Mechanism—The kinetics of [Ca2]i release was further ana-
lyzed by using three different concentrations for each Wnt
ligand. Box-whisker plots for the rise, dwell, and fall time as a
function of low, medium, and high concentrations of eachWnt
ligand is given in supplemental Figs. S2–S7). Time constants
were significantly different between at least two different con-
centrations forWnts 3A, 4, 5A, 9B, and 10B (supplemental Figs.
S2-S4, S6, and S7), but no difference in these time constantswas
observed for Wnt7A (supplemental Fig. S5). We compared the
DT constants forWnts 3A, 4, 5A, 9B, and 10B in more detail to
elucidate the mechanisms of [Ca2]i release by fitting the DT
data to calculate the reaction-rate expression for a first-order
reaction (Fig. 4). Strikingly, Wnts 3A, 4, 9B, and 10B show neg-
ative cooperativity but notWnt5A.Negative cooperativity indi-
cates a decrease in function (DT) as the ligand concentration
increases; the rate constants for Wnts showing negative coop-
erativity are given in Fig. 4. Wnt5A was the only [Ca2]i acti-
vating Wnt ligand that follows the classical Michaelis-Menten
kinetics, with a half-maximal concentration of 67 ng/ml. These
results provide the first evidence of negative cooperativity of
binding ofWnts (3A, 4, 9B, and 10B) to their receptor and show,
also for the first time, that the molecular dynamics of [Ca2]i
release, via receptor/ligand interaction by differentWnts, could
provide critical regulatorymechanisms ofWnt/Ca2 signaling.
[Ca2]i Release Results in Increased Intranuclear Ca2 and
Altered Electrical Activity in the Nucleus—Calcium is a key reg-
ulator of the electrical activity in the nucleus (23). Intranuclear
concentration of Ca2 follows increase in cytosolic Ca2 (29).
We therefore investigated changes in intranuclear calcium and
membrane potential using cells loaded with Fluo4 and FM4-64
with or without Wnts in PC3 and MCF cells. There was an
increase in the [Ca2]i (Fluo4) signal in the green channel
(500–560 nm) upon addition of the Wnt ligands in these cells
(supplemental Movies SM14 and SM15). After 300 s, there
was an increase in the intensity of the FM4-64 signal in the red
channel (650–800 nm); there was depolarization of the cell
FIGURE 1. Representative trace of intracellular calcium release in PC3
cells in response to addition of 100 ng/ml Wnt ligand peptide (gray,
Wnt3A; red, Wnt4; green, Wnt5A; pink, Wnt7A; blue, Wnt9B; brown,
Wnt10B; violet, Wnt11; yellow, vehicle control). All of the Wnts tested,
except for Wnt11, induce intracellular calcium mobilization in PC3 prostate
cancer cell line. The x axis is time (s), and the y axis is the ratio of Fluo4/Fura
Red (see the supplemental Movie for each ligand). The waveform for each
ligand was used to calculate time constants (rise, dwell, and fall time) of cal-
cium release.
FIGURE 2. [Ca2]imeasurements weremade as described under “Experi-
mental Procedures” using Fluo4 and FuraRed dyes. Thapsigargin (at 5M
final concentration)was addedat the time indicated (arrow). A representative
trace of a calcium transient (cyan) evoked after the addition of thapsigargin is
shown. The calcium signal (ratio of Fluo4/FuraRed) declined after an initial
rise to reach the baseline within 120 s. In PC3 cells incubated with thapsi-
gargin (5 M) for 15 min, addition of Wnt5A (100 ng/ml, green), Wnt9B (200
ng/ml, blue), or Wnt 10B (200 ng/ml, brown) did not evoke an increase in
[Ca2]i as seen in untreated PC3 cells (Fig. 1).
ANew, ConvergentModel ofWnt Signaling inMammalian Cells
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membrane, as expected (Fig. 5). There was also an increase in
the intensity of FM4-64 around the nucleus, indicating a depo-
larization of the transnuclear envelope potential in PC3 cells
(Fig. 5; and for MCF7 cells, supplemental Fig. S8).
Wnt/Ca2 Signaling and Cell Motility—One functional con-
sequence of inhibition of downstreamWnt/Ca2 signaling is a
decrease in cell motility (14). To test whether inhibition of
Wnt/Ca2 signaling by Wnt/canonical signaling ligands such
as Wnt9B and 10B, we used the wound scratch assay in which
Wnt-induced [Ca2]i release was inhibited by thapsigargin
(supplemental Fig. S9). The rate of wound closure in wounded
PC3 cells in the presence ofWnt 5A or 9B was similar to that of
control untreated cells (supplemental Fig. S9). However, there
FIGURE 3. Box plot for time constants of the Wnt-induced calciumwave-
form. The time constants (A, rise; B, dwell; and C, fall times) were calculated
from calcium waveform generated by the addition of each Wnt ligand (100
ng/ml) to PC3 cells. Significance of difference was calculated using a Mann-
Whitney U test. All time constants were compared with Wnt3A, primarily;
subsequent comparisons (e.g.Wnt4 to Wnt5A, Wnt4 to Wnt7A etc) are listed
in descending order on top of box plots for each subsequent Wnt. ns, differ-
ence was not statistically significant.
FIGURE4.Wnts that activate [Ca2]i release shownegative cooperativity.
Wnts 3A (gray), 4 (red), 9B (blue), and 10B (dark blue) showed decreasing and
significant difference between at least two incremental increasing concen-
trations for the dwell time for [Ca2]i release. The dwell time constant at
increasing Wnt concentration are fitted to a first-order reaction equation
(y0A1e (x/t1)), where y0 is Y offset, A1 is amplitude; and t1 is decay con-
stant. The rate constant for the reaction (k) is given in brackets for each Wnt
ligand. No significant difference was found in the dwell times for different
concentration for Wnt7A, and therefore, the data is not considered for this
analysis. Wnt5A (green) showed a classic Michaelis-Menten kinetics with an
estimated K1⁄2 of 67 ng/ml.
FIGURE 5. [Ca2]i release results in an increase in intranuclear Ca
2 con-
centration. Snapshots of three time points (A–C) at t  20, 110, and 250 s
(A–C) in PC3 cells loaded with Fluo4 (green) and FM4 (red) are shown and
treated with Wnt5A (100 ng/ml). Quantitative expression of the increase in
cytosolic (red line, [Ca2]i) and intranuclear Ca
2 (violet line) is given in D. At
t  20 (A), steady state, base-line [Ca2]i as a function of Fluo4 intensity is
shown that shows an increase at t 110 s (B), subsequent to the addition of
Wnt5A (blackarrow), increase in [Ca2]i is initiated (redarrow)withan increase
in intranuclear Ca2 following shortly (33 s) later (violet arrow). At t 250 s
(C), there is an increase in the FM4 signal in the cell and nuclear membranes
(brown arrows). A representative from three independent measurements is
shown. Imagingwas performedon Leica SP2 confocal andDMRBmicroscope
with 20  0.8 numerical aperture water dipping objective and 12-bit gray
depth using similar conditions to the FV1000.
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was a significant decrease in the rate of wound closure in cells
treated with thapsigargin even in the presence of Wnt ligands.
These results indicate that downstream mechanisms of Wnt/
Ca2 signaling are similar for the classical non-canonical (Wnt
5A) or canonical (Wnt 9B) Wnt ligands. Similar results were
obtained for Wnts 3A and 10B when [Ca2]i was inhibited by
incubation with thapsigargin (supplemental Table 1).
Translocation of -Catenin to the Nucleus Subsequent to
Nuclear Membrane Depolarization—-Catenin expression
was determined subsequent to Wnt ligand activation and
[Ca2]i release using immunofluorescence. Compared with
vehicle controls, there was an increased in expression of
-catenin in PC3 cells treated with Wnts5A, 9B, and 10B (Fig.
6). There was little expression of -catenin in vehicle-treated
cells (Fig. 6A); the expression of-catenin is visibly increased in
PC3 cells treated with Wnt5A (Fig. 6B), Wnt9B (Fig. 6C), and
Wnt 10B (Fig. 6D) and is visible in the nucleus. Similar results
were obtained forWnt 3AandWnt4 in PC3 cells (supplemental
Fig. S10). Co-localization of -catenin and DAPI signals was
quantified using Fiji software (38) as described under “Experi-
mental Procedures.” There was a significant increase in the
Pearson coefficient of nuclear co-localization of -catenin
when cells were exposed toWnts 3A, 4, 5A, 9B, and 10B (Fig. 7
and supplemental Table 2). Furthermore, inhibition of Wnt-
induced [Ca2]i release, by incubation of cells with thapsi-
gargin, reduced the translocation of -catenin into the nucleus
(supplemental Fig. S11), indicating a link between -catenin
translocation, store-operated, thapsigargin-inhibitable [Ca2]i
release and perhaps alterations in nuclear envelope potential.
Wnt ligands are known to phosphorylate their cell surface
co-receptors (LRP5/6 (low density lipoprotein receptor-related
protein 5/6) (40)), an early event in Wnt signaling activation
(41). It appears that both Wnt5A and Wnt9B phosphorylate
LRP6 co-receptors in PC3 cells (supplemental Fig. S12).
We also used the paradigm ligands of the Wnt classes (as
categorized in Fig. 3) in two other cell lines to determine that an
increase in [Ca2]i release was followed by translocation of
-catenin to the nucleus. The data for MCF7 and 253J cells,
with -catenin expression visible in the cell nucleus after treat-
ment with Wnt ligands, are shown in supplemental Fig. S13.
These results indicate that increase in [Ca2]i in response to a
variety of Wnt ligands leads to a depolarization of the nuclear
envelope and -catenin translocation from the cytosol to the
nucleus.
DISCUSSION
Wnt signaling is categorized into independent, canonical,
and non-canonical pathways, with -catenin as a key trans-
ducer of the former and Ca2 as a major effector molecule for
the latter (other non-canonical pathways include the planar cell
polarity (42, 43) and cGMP/phosphodiesterase pathways (44)).
The Wnt/-catenin pathway is used as a synonym for the
canonical pathway (45–47). The categorization is not absolute
as recent examples show some cross-talk (21, 22); however, the
distinction of -catenin-dependent and -independent path-
ways to describe Wnt signaling remains unresolved (7). In this
report, we have addressed two key questions regarding Wnt
signaling in mammalian cells: 1) which and how many Wnt
ligands can mobilize intracellular calcium and 2) what are the
mechanisms of -catenin entry into the nucleus? Our data
show for the first time that in mammalian cells, six of the seven
Wnts tested in a direct calcium measurement assay mobilize
[Ca2]i, including Wnt ligands previously thought to act only
via -catenin pathway (e.g. Wnt 9A and 10B) (Fig. 1 and sup-
plemental Movies SM1–SM7). A discharge of [Ca2]i from the
endoplasmic reticulum and inhibition of microsomal Ca2-
ATPase by incubation of cells with thapsigargin abolished the
increase in Wnt-induced [Ca2]i release (Fig. 2) and reduced
-catenin translocation to the nucleus (supplemental Fig. S11).
Thapsigargin is resuspended in dimethyl sulfoxide. Dimethyl
sulfoxide induces Ca2 spikes in a variety of cells (48); our
results in PC3 cells concur with previous observations (supple-
mental Fig. S14). Thapsigargin also induced Ca2 transient,
which declined to reach the base line within 120 s (Fig. 2). How-
FIGURE 6. -Catenin (red) translocation to the nucleus (counterstained
with DAPI, blue) in response to activation byWnt ligands (100 ng/ml) in
in PC3 prostate cancer cell line, control (A) or after activationwithWn5A
(B), Wnt 9B (C), and Wnt 10B (D). Cells were grown in eight-well chamber
slides, treated withWnt ligands, fixed, and stained for -catenin using proto-
cols described under “Experimental Procedures.” Z-stacks obtained using an
Olympus confocal system are shown. Representative images of three individ-
ual experiments are shown. Scale bar, 10 m.
FIGURE 7. Box plots of calculated Pearson co-localization coefficient of
-catenin translocation to the nucleus. Immunohistochemistry and image
analysis was performed as described under “Experimental Procedures.”
Between 20–97 cells from two to three independent experiments were ana-
lyzed. Circles represent means of Pearson co-localization coefficient for each
condition. Cy3 (label for -catenin) showed significantly (p  0.001, Mann-
Whitney test; see supplemental Table 2) increased co-localization coefficients
for Wnt-treated (100 ng/ml) versus control cells.
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ever, a 15-min incubation with dimethyl sulfoxide had no effect
on Wnt-induced increase in [Ca2]i (supplemental Fig. S14),
unlike thapsigargin treatment, which abolished Wnt-induced
[Ca2]i release (Fig. 2), indicating that Wnt activates store-op-
erated Ca2 release.
The results presented here provide first evidence that key
transducers of canonical and non-canonical pathways converge
to activate Wnt signaling in mammalian cells. A new conver-
gent model of Wnt signaling network is proposed (Fig. 8), in
which multiple Wnt ligands in a variety of mammalian cell
lines, increase free intracellular and nucleoplasmic Ca2, depo-
larize theNE, and increase the translocation of-catenin to the
nucleoplasm, suggesting a coupled rather than independent
Wnt/Ca2 and -catenin pathway.
Categorization of Wnt Ligands and Distinction into Canoni-
cal and Non-canonical Pathways—The classification of Wnt
ligands mediated signaling via the -catenin or calcium path-
ways is largely based upon their ability to induce a secondary
axis in Xenopus embryos (49) or their ability to transform C57
mg cells (50). Ecotopic expression ofWnts such asWnt1, 3A, 8,
and 8B was found to induce a secondary axis in Xenopus
embryo and stabilize -catenin and otherWnts such asWnt5A
and 11 did not (12). Members of the Wnt1 class includeWnt1,
Wnt2, Wnt3, Wnt3A, Wnt8, Wnt8B, and Wnt10B (Wnt1
shares 96% identity in amino acid sequence to Wnt10B and
overlap in function (51)) and induce secondary body axis in
Xenopus and activates the canonical Wnt/-catenin pathway.
TheWnt5A class cannot induce secondary body axis formation
inXenopus and includesWnt4,Wnt5A,Wnt5B,Wnt6,Wnt7A,
and Wnt11 (see Ref. 52 for a review). Studies in zebrafish
embryos indicate that Wnt5A and Wnt11 but not Wnt8 over-
expression induce calcium release (11). However, little is
known about the ability of Wnts, other thanWnt5A, to induce
[Ca2]i release in prostate or other mammalian cells.
However, these distinctions have been blurred when it was
shown that Wnts associated with the so-called non-canonical
pathway are capable of transforming cells in culture (13, 53, 54).
In addition, the ligands ofWnt family are likely to share the cell
membrane receptor, and most cells are exposed to a variety of
Wnt ligands simultaneously. A balance of these signals and the
pathways theymight activate (e.g.Wnt/-catenin orWnt/Ca2
or both) could determine, for example, cell fate of a stem cell or
whether cancer cells metastasize (e.g. by acquiring increased
capacity for motility). Wnt 11 is the only ligand tested in our
study that did notmobilize [Ca2]i (supplementalMovie SM8).
A possible explanation for this may reside in primary amino
acids that deviates from the consensus Wnt sequence in five
amino acid residues, in close proximity to RWNC motif (sup-
plemental Fig. S15).
-CateninTranslocation intoNucleus Subsequent to Increase
NucleoplasmicCa2andDepolarization of theNE—Macromo-
lecular transport across the NE is comprised of a variety of
independent and interdependent biochemical and electro-
chemical processes (23, 24). These may involve a nuclear local-
ization signal binding of proteins intended for the nucleus with
other cytosolic proteins to facilitate their entry requiring ener-
gy-dependent mechanisms or phosphorylation of specific pro-
teins (55). Although -catenin does not contain nuclear local-
ization signal, by using in vitro, biochemical experiments,
Sharma and colleagues (56) have shown that this recognition
may occur by the interaction of the Arm domain of -catenin
with NPC component proteins. Upon reaching the outer NE in
response Wnt signaling, -catenin faces considerable barriers
to entry into the nucleoplasm. Sharma et al. (56) describe the
targeting of-catenin to the outerNE, but their experiments do
not explain how -catenin may overcome significant biophys-
ical hurdles (amolecularmass of 92 kDa and an overall negative
charge of20.8 at pH 7.0) to traverse the NE.
Othermechanisms involve silencing of NPC channel activity
for transport of medium-sized (40 kDa) transcription factors
(such as NFB or SP1) (57). Ca2 ions also play a role in the
trans-NE transport of macromolecules (31), and it has been
proposed that depletion of intranuclear Ca2 can inhibit mac-
romolecular transport of particularly intermediate size (70
kDa) but also small (10 kDa) macromolecules across NE (25).
Translocation of-catenin, a 92-kDa transcription factor, from
the cytosol to the nucleus is a key event in the so-called canon-
FIGURE 8. A convergent model for the canonical (Wnt/-catenin) and
non-canonical (Wnt/Ca2) Wnt signaling, in mammalian cell lines (only
the cell membrane and the nucleus shown in the schematic for clarity).
Proposed steps ofWnt signaling inmammalian cells are as follows: bindingof
Wnts (3A, 4, 5A, 7, 9B, and 10B) (1) results in the activation of intracellular
calcium stores (2) that increase in the intracellular concentration of free store-
operated calcium ((3) Figs. 1–3 and supplemental Movies). The increase in
free calcium depolarizes the cell membrane (supplemental Movies) and as
calcium enters the nucleus (4), the NE is depolarized (Fig. 5 and supplemental
Movies); the calculated diffusion constants for the activation of bound to free
intracellular calcium is 0.21m/s, and time constants for steps 1 to 4 are likely
to be inmilliseconds.Wehave shown, previously, that activationofWnt/Ca2
pathway by Wnt5A increases (5) Ca2/calmodulin-dependent kinase
(CamKII) activity to induce cytoskeletal modulation in prostate cancer cells
(14). It is well established by previous studies (see Ref. 7 for a review) that
activation of Wnt signaling (6) desequesters the caged -catenin (-cat) that
is phosphorylated (P) andubiquitinated (UUU) prior to degradation in protea-
somes, gray square) in the cytosol. The desequestered -catenin (7) translo-
cation is facilitated across theNE (Fig. 5), which is nowdepolarized (8) andhas
increased nucleoplasmic calcium (9). -Catenin is now co-localized in the
nucleus (Figs. 6 and7)where it is known tobind to LEF/TCFproteins to initiate
gene transcription. For simplification, many other proteins involved in Wnt
signaling are not shown andmultiple other pathways such asWnt/PCP path-
ways are not included in the illustration. The steps forwhich evidence is given
in the manuscript are shown with arrows shaded purple. See supplemental
Movie SM16 for an animated version of the proposed model.
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ical Wnt signaling; however, the mechanism of this transloca-
tion is not known. The increase in intranuclear Ca2 and depo-
larization of the nuclear membrane (Fig. 5 and supplemental
Fig. S8) and reduction in -catenin translocation into the
nucleus in the presence of thapsigargin (supplemental Fig. S11)
suggest a putative role ofmembrane potential regulating ions as
regulators of Wnt signaling in PC3 cells.
In the convergent model of Wnt signaling in mammalian
cells proposed here (Fig. 8), binding of a variety of Wnt ligands
to their receptors activates [Ca2]i release (Fig. 1). The sharp
and transient increase in [Ca2]i results in the increased
intranuclear Ca2within 300 s ofWnt ligand activation (Fig. 5).
Subsequent to intranuclearCa2 increase anddepolarization of
the NE, there is also an evident increase in the nuclear expres-
sion of-catenin (Figs. 6 and 7). Themodel presented here does
not exclude upstream homing events that may direct -catenin
to the NE or downstream events such as involvement of energy
expenditure or other biochemical and macromolecular trans-
port mechanisms that may also facilitate the ultimate translo-
cation of -catenin into the nucleus. It, however, includes an
important and as yet unconsidered electrochemical aspect in
the transport of -catenin into the nucleus where its functional
activity lies. It also suggests, at least in mammalian cell lines, an
integrated signaling process that can facilitate, amplify and reg-
ulate activities of multiple transducers activated by individual
ligands (Fig. 8).
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